Skip To Main Content

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content
Utility of Pregnancy - Adapted Years Algorithm in Diagnosis of Pulmonary Embolism

Utility of Pregnancy - Adapted Years Algorithm in Diagnosis of Pulmonary Embolism

Findings from a multicentre prospective Artemis study.

ACC/AHA vs ESC/EAS LDL–C recommendations for residual risk reduction in ASCVD: A simulation study from Da Vinci

ACC/AHA vs ESC/EAS LDL–C recommendations for residual risk reduction in ASCVD: A simulation study from Da Vinci

Event rates and Risk Factors for Recurrent CV Events

Event rates and Risk Factors for Recurrent CV Events

New technologies in Type 2 Diabetes management and future opportunities to improve clinical outcomes

New technologies in Type 2 Diabetes management and future opportunities to improve clinical outcomes

This session emphasizes that new technology in Diabetes management not only can overcome common barriers in achieving glycemic control in people with T2D but also may facilitate more effective and efficient Diabetes care.

Role of Genetic Testing in Management of Dyslipidemia

Role of Genetic Testing in Management of Dyslipidemia

Insulin Treatment Intensification with GLP - 1RA vs Basal - Plus/Basal - Bolus Regimens

Insulin Treatment Intensification with GLP - 1RA vs Basal - Plus/Basal - Bolus Regimens

Act Now for Your ACS Patients: Optimize Your ACS Pathway

Act Now for Your ACS Patients: Optimize Your ACS Pathway

Hospitalization Rates for Acute Diabetes Complications Before and After Flash Glucose Monitoring Initiation Among People with Type 1 or Type 2 Diabetes in France: The Relief Study

Hospitalization Rates for Acute Diabetes Complications Before and After Flash Glucose Monitoring Initiation Among People with Type 1 or Type 2 Diabetes in France: The Relief Study

Why Sanofi Pasteur?

Why Sanofi Pasteur?

PCSK9 Inhibitors in Cardiovascular Disease

PCSK9 Inhibitors in Cardiovascular Disease

LLTs and Antithrombotic Therapy in PAD

LLTs and Antithrombotic Therapy in PAD

Post Thrombotic Syndrome in Women

Post Thrombotic Syndrome in Women